Trials / Completed
CompletedNCT02570360
Exercise and Treatment-as-usual in Substance Use Treatment Outcomes
Comparative Effects of Exercise and Treatment-as-usual on Abstinence, Craving, and the Endocannabinoid System in Substance Users
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The research study compares the substance abuse treatment outcomes (e.g., craving, withdrawal symptoms, rates of use, abstinence) of standard intensive outpatient care, with or without an added 6-wk aerobic exercise component. In addition, certain biomarkers associated with both exercise and substance use (e.g., endocannabinoids and cortisol) will be assessed. In a rolling admissions format over the course of a year, approximately 36 treatment-seeking substance users who are currently receiving Intensive Outpatient Treatment through a local Alcohol or Other Drug Abuse agency will be randomized to either receive 6 weeks aerobic exercise training in addition to standard care or standard care with 6 weekly laboratory visits to complete questionnaires (18 per group).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | exercise | The EX participants will engage in supervised, individual treadmill exercise 3xs/wk at the UW Natatorium. Sessions will consist of a 5-minute warm-up followed by 30 minutes of a moderate to moderately-high intensity exercise and then finish with a 5-minute cool down. Questionnaires will be completed before and after exercise on a weekly basis. |
| BEHAVIORAL | treatment-as-usual | The control (standard care) participants will come to the UW-Natatorium on a weekly basis to complete questionnaires. |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2015-10-07
- Last updated
- 2019-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02570360. Inclusion in this directory is not an endorsement.